A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis

Inclusion Criteria

• •Male or female between 2 and 18 yrs old, inclusive, who has documented RRP.
• •Patients with documented RRP
• •Subject is surgically debulked within 7 days before the first dose of SGN-00101.
• •Subject has had at least 4 debulking surgeries for RRP, had no intersurgical intervals greater than 84 days during the period of the last 4 surgeries.
• •Subject is free of life threatening or serious concomitant disorders other than the disease under study.
• •Females of childbearing potential must have a negative pregnancy test and must be practicing an effective/appropriate method of birth control as determined by the Investigator.